Frederick Ehret, MD
Plastic and Reconstructive Surgery · Tacoma, WANPI 1639153232
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (39.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by AbbVie at 47.8% of the total.
Across 102 payments — averaging $119.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Motiva USA, LLC$5K
- Sientra, Inc.$947
- Mentor Worldwide LLC$327
- Davol Inc.$271
- Amgen$141
- plus $191 from 5 others
What the payments were for
- Consulting fees$2,50020%
- Travel & lodging$8127%
- Food & beverage$4,07033%
- Gifts$4,84140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $5,838 |
| Motiva USA, LLC | 16 | $4,508 |
| Sientra, Inc. | 18 | $947 |
| Mentor Worldwide LLC | 7 | $327 |
| Davol Inc. | 3 | $271 |
| Amgen | 2 | $141 |
| Baxter Healthcare | 4 | $86 |
| Integra Lifesciences Corporation | 1 | $37 |
| Merck | 2 | $29 |
| Merz North America, Inc. | 1 | $22 |
| Galderma Laboratories, L.p. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,223 in reported general payments places this provider in the 85th percentile of 63 plastic and reconstructive surgery providers in Washington.
See all plastic and reconstructive surgery providers in Washington →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 36 | $222 |
| Ondansetron OdtOndansetron | 29 | $216 |
| Mupirocin | 21 | $186 |
| Hydroxyzine Hcl | 14 | $178 |
| Scopolamine | 11 | $141 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Tacoma
- Mehmet UluerTacoma$2K
- Ross RealicaTacoma$1K
- Melissa LarsenTacoma$654
- Khashayar DehghanTacoma$480
- Danielle HayesTacoma$107
- Todd WillcoxTacoma$57
- Kelly KafkaTacoma$22
- Vincent MuonekeBurien$84K
- Fredric SternBellevue$38K
- Srinivas SusarlaSeattle$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.